Recent News

  • Wednesday, January 18, 2017 - 09:45
  • Saturday, December 24, 2016 - 19:00

    We recently showed that duplication of the TBK1 gene causes human glaucoma that occurs at low intraocular pressure. In this study, we engineered mice to have an extra copy of the TBK1 gene in its genome. These mice develop glaucoma that occurs at normal eye pressures, just like the glaucoma in our patients with a TBK1 gene duplication. The results of this study provide the strongest proof that mutations in the TBK1 gene causes human glaucoma and the mice will be a powerful resource for studying the causes and testing cures for human glaucoma. Read more about this research here.

  • Thursday, December 22, 2016 - 10:45
  • Wednesday, December 21, 2016 - 11:00

    Mae Gordon PHD is a Professor of Ophthalmology and Visual Sciences and a Professor of Biostatistics at Washington University. On December 20th she presented a lecture, “Strategies for Increasing Rigor in Ophthalmology Research” for Grand Rounds at the University of Iowa. Dr. Gordon has been a leader of the Ocular Hypertension Treatment Study (OHTS) which has been one of the most successful and influential treatment studies in ophthalmology. She has also served as member of the National Advisory Eye Council for the NIH. Dr. Gordon directs the Vision Research Coordinating Center and Washington University and she has authored over 150 research articles. Read more about Dr. Gordon here.

  • Friday, December 2, 2016 - 08:15

    University of Iowa resident physician, Dr. Mathew Miller and faculty members Dan Bettis and John Fingert authored an article reviewing the utility of genetic testing for glaucoma in 2016. Read more about it here.

  • Monday, November 21, 2016 - 06:45

    A research team led by Drs. Kuehn and Kwon designed a new formulation of the standard timolol glaucoma medicine that successfully lowered eye pressure for up to 90 days in animal studies. The team engineered a long-lasting form of timolol that is injected underneath the outer covering of the eye (the conjunctiva) where it has pressure-lowering effects for months. Read more about the development of this new formulation of timolol here.

  • Wednesday, October 26, 2016 - 18:45

    Glaucoma Center faculty Dr. Wallace LM Alward and John H Fingert discuss genetic testing and glaucoma in an article by the American Academy of Ophthalmology’s EyeNet. Read the article here.

  • Monday, October 10, 2016 - 11:15

    Dr. Fingert was a speaker in a glaucoma genetics session at the biennial meeting of the International Society of Eye Researchers. Dr. Fingert is shown here with Janey Wiggs (Harvard, USA), Michael Hauser (Duke, USA), Mineo Ozaki (Ozaki Eye Hospital, Japan), Rand Allingham (Duke, USA), and Tin Aung (Singapore Eye Research Institute, Singapore).

  • Monday, October 3, 2016 - 10:30

    Our genetic analysis of the Ocular Hypertension Treatment Study (OHTS) investigated the effect of genetic risk factors on the probability of participants with high intraocular pressure going on to develop glaucoma. We found that OHTS participants that carry a genetic risk factor in the TMCO1 gene have a significantly higher probability of developing glaucoma. Read more about this study here.

  • Thursday, September 22, 2016 - 14:00

    The American Academy of Ophthalmology announced that Dr. Young Kwon is a recipient of the 2016 Senior Achievement Award for his contributions to the Academy, its scientific and educational programs and to ophthalmology. Read more about this award here.

Pages